BEIS Announcement

The Department for Business, Energy and Industrial Strategy (BEIS) has today announced the up to £6 million Medical Radionuclide Innovation Programme (MRIP). 

MRIP will focus on encouraging innovation in technologies and techniques that could support access to medical radionuclides and ensuring HMG has access to the evidence base required to take informed decisions in the future. 

The programme has been broadly designed around the following three workstreams:
Medical Radionuclide Landscape Assessment and Scenario Analysis – This piece of work will look at building the evidence HMG require to understand future supply and demand in the UK and make informed decisions in the future. This piece of work will take place in two phases, with phase 1 hopefully kicking off in January 2023. 

Nuclear Materials Access – We are working with the Nuclear Decommissioning Authority and their Site Licensed Companies to better understand whether there are materials of value held within the UK Radioactive “Waste” Inventory and how accessible/useful they are. This work is already underway.

Innovation Project Workstream – We would like to support the development of technologies that could support our future access to medical radionuclides through this workstream. The exact design of this will be informed by market/stakeholder engagement (see below).

Article on LInkedin;https://www.linkedin.com/posts/beisgovuk_lifesciences-activity-7007491663434502144-k1Lu/?utm_source=share&utm_medium=member_desktop

The BNMS have registered as stakeholders in the programme.